Development and application of a highly sensitive LC-MS/MS method for simultaneous quantification of N,N-dimethyltryptamine and two of its metabolites in human plasma.
DMT
LC-MS/MS
Metabolites
N,N-dimethyltryptamine
Pharmacokinetics
Psychedelic
Journal
Journal of pharmaceutical and biomedical analysis
ISSN: 1873-264X
Titre abrégé: J Pharm Biomed Anal
Pays: England
ID NLM: 8309336
Informations de publication
Date de publication:
01 Apr 2022
01 Apr 2022
Historique:
received:
28
06
2021
revised:
31
01
2022
accepted:
01
02
2022
pubmed:
13
2
2022
medline:
16
3
2022
entrez:
12
2
2022
Statut:
ppublish
Résumé
A highly sensitive LC-MS/MS method for the quantification of N,N-dimethyltryptamine (DMT) and its metabolites indole-3-acetic acid and DMT N-oxide in human plasma has been developed and validated. Chromatography was performed using a diphenyl column with gradient elution (0.1% formic acid in methanol/water). The mass spectrometer was operated in multiple reaction monitoring mode. A methanolic solution containing internal standards 2-methylindole 3-acetic acid and deuterated DMT, was added to plasma samples, followed by protein precipitation with acetonitrile. The samples were centrifuged and supernatants transferred to new tubes and evaporated to dryness before reconstitution in aqueous mobile phase. The method was validated with regards to accuracy, precision, sensitivity, selectivity, recovery, matrix effects, stability, carry-over and dilution integrity. The validated linear range was 0.25-200 nM for DMT and 15-250 nM for DMT N-oxide. For the endogenous compound indole-3-acetic acid a different approach was taken due to its significant presence in blank samples. The change in signal response from a blank sample was used when constructing the calibration curve with linearity demonstrated between elevations of 500-5000 nM above the blank. Applicability of the described method was demonstrated through analysis of plasma samples from healthy volunteers having received intravenous injections of DMT. The presented method for rapid and sensitive quantification of DMT and its metabolites in human plasma can be applied to future studies aiming to characterize DMT disposition and its relationship to immediate psychedelic or long-term antidepressive effects.
Identifiants
pubmed: 35149418
pii: S0731-7085(22)00063-2
doi: 10.1016/j.jpba.2022.114642
pii:
doi:
Substances chimiques
N,N-Dimethyltryptamine
WUB601BHAA
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
114642Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier B.V. All rights reserved.